首页> 美国卫生研究院文献>Scientific Reports >Herb pair Danggui-Honghua: mechanisms underlying blood stasis syndrome by system pharmacology approach
【2h】

Herb pair Danggui-Honghua: mechanisms underlying blood stasis syndrome by system pharmacology approach

机译:草药对当归-宏华:系统药理学方法研究血瘀证的潜在机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Herb pair Danggui-Honghua has been frequently used for treatment of blood stasis syndrome (BSS) in China, one of the most common clinical pathological syndromes in traditional Chinese medicine (TCM). However, its therapeutic mechanism has not been clearly elucidated. In the present study, a feasible system pharmacology model based on chemical, pharmacokinetic and pharmacological data was developed via network construction approach to clarify the mechanisms of this herb pair. Thirty-one active ingredients of Danggui-Honghua possessing favorable pharmacokinetic profiles and biological activities were selected, interacting with 42 BSS-related targets to provide potential synergistic therapeutic actions. Systematic analysis of the constructed networks revealed that these targets such as HMOX1, NOS2, NOS3, HIF1A and PTGS2 were mainly involved in TNF signaling pathway, HIF-1 signaling pathway, estrogen signaling pathway and neurotrophin signaling pathway. The contribution index of every active ingredient also indicated six compounds, including hydroxysafflor yellow A, safflor yellow A, safflor yellow B, Z-ligustilide, ferulic acid, and Z-butylidenephthalide, as the principal components of this herb pair. These results successfully explained the polypharmcological mechanisms underlying the efficiency of Danggui-Honghua for BSS treatment, and also probed into the potential novel therapeutic strategies for BSS in TCM.
机译:在中国,草药对当归-红花已被广泛用于治疗血瘀证(BSS),这是中药(TCM)最常见的临床病理综合征之一。但是,其治疗机理尚未清楚阐明。在本研究中,通过网络构建方法开发了一种基于化学,药代动力学和药理学数据的可行的系统药理模型,以阐明该药草对的机理。当归红花的三十一种活性成分具有良好的药代动力学特征和生物学活性,并与42个BSS相关靶标相互作用,以提供潜在的协同治疗作用。对构建网络的系统分析表明,这些靶标如HMOX1,NOS2,NOS3,HIF1A和PTGS2主要参与TNF信号通路,HIF-1信号通路,雌激素信号通路和神经营养蛋白信号通路。每种活性成分的贡献指数还显示了六种化合物,其中包括羟基红花黄A,红花黄A,红花黄B,Z-ligustilide,阿魏酸和Z-丁叉萘。这些结果成功地解释了当归-宏华治疗BSS的疗效的多种药物学机制,并探讨了BSS在中医中潜在的新型治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号